TNF and inflammatory bowel disease: Although previous inflammatory bowel disease (IBD) studies have implicated activated fibroblasts13,14,28, neutrophils26–28, inflammatory monocytes13,29 and activated T and IgG+ plasma cells8,13 with anti-TNF nonresponse, no biomarker is currently approved for response prediction.